Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $48.0800 (0.97%) ($47.3500 - $48.3500) on Tue. Nov. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 51 | Latest Price | $48.0800(0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.5% a day on average for past five trading days. | Weekly Trend | BAX declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) VYM(51%) SPY(49%) IVE(48%) | Factors Impacting BAX price | BAX will decline at least -0.56% in a week (0% probabilities). TLT(-17%) VIXM(-16%) GDXJ(-9%) UUP(-5%) TIP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $47.26(1.74%) | 10 Day Moving Average | $47.23(1.8%) | 20 Day Moving Average | $47.57(1.07%) | To recent high | -2.2% | To recent low | 6.6% | Market Cap | $24.53b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |